Nalmefene (Avior Bio)
纳美芬 (Avior Bio)
Report date: 2024/02/05 16:47:09
Base Information
Drug NameNalmefene (Avior Bio)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvior Inc
China Registration ClassN/A
Develop Information
Active CompaniesTharimmune IncAvior Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A